EMS Limited (EMSLIMITED)
Transcript of Earnings Conference Call held on August 13, 2026 for quarter ended June 30, 2026
AI summary
- Q1 FY27 standalone revenue Rs. 125.72 Cr (+50% q-q), EBITDA margin 25.53%, PAT Rs. 15.03 Cr (+184.65% q-q)
- Consolidated revenue Rs. 157.24 Cr (+30% q-q), EBITDA Rs. 28.14 Cr (+31.62%), PAT Rs. 15.49 Cr (+1.28%)
- Order book Rs. 2329 Cr as of July 2026; Rs. 317 Cr work orders secured in Q1, Rs. 158 Cr in Q2 so far
- Execution on West Bengal project expected to normalize from Q3 FY27
- FY27 revenue guidance: Rs. 900-950 Cr, with 50% growth over last year; margins expected to return to 2024-25 levels
- Working capital cycle approx. 120 days; revenue ramp-up and margin recovery expected in H2 FY27
- Project timelines typically 2-3 years; revenue starts 6-7 months post work order
- No CAPEX plans currently; Q2 weaker than Q1 but Q3 and Q4 expected to show strong growth
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 EMSLIMITED — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add EMSLIMITED to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on EMS Limited
Important.
The summary above is generated automatically from EMS Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.